BOT 1.18% 42.0¢ botanix pharmaceuticals ltd

Ann: Trading Halt, page-104

  1. 553 Posts.
    lightbulb Created with Sketch. 469
    So if I am understanding this they received royalties from Kaken until SB was bought by Botanix. We can see that during this time Kaken results were ramping up. Say $80k per qrt to be conservative = annualized is $US 320,000 convert to AUS $ 470,000. 10 % royalty? Is Kaken making $3.2 million in start of sales first year? Thoughts? we know they are selling around 300,000 units now. We know that Ecclock sells for about US $46 for a 2 week supply which equates to almost $14 million. Something is not fitting unless the ramp up of Ecclock sales was very quick and they were being paid with a lag from previous qrtrs. Interested in others thought.
    Last edited by Nnyck777: 19/07/23
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
42.0¢
Change
-0.005(1.18%)
Mkt cap ! $761.8M
Open High Low Value Volume
43.0¢ 44.5¢ 41.5¢ $2.435M 5.697M

Buyers (Bids)

No. Vol. Price($)
20 819538 41.5¢
 

Sellers (Offers)

Price($) Vol. No.
42.0¢ 29052 2
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.